Visken (pindolol) / Novartis 
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Visken (pindolol) / Novartis
NCT06028321: Study of Comparative Bioavailability and Pharmacokinetics of ACM-001.1) and Pindolol in Healthy Volunteers (HV)

Completed
1
51
Europe
Part 1 Group 1 Regime A (ACM-001.1), Part 1 Group 2 Regimen C (Pindolol), Part 2 Group D (Pindolol), Part 2 Group E (ACM-001.1), Part 2 Group F (ACM-001.1 ), Part 2 Group G (ACM-001.1), Part 1 Group 1 Regimen B (Pindolol), Part 1 Group 1 Regimen A (Placebo), Part 2 Group E (Placebo), Part 2 Group F (Placebo), Part 2 Group G ( Placebo)
Actimed Therapeutics Ltd, Quotient Sciences
Cachexia
06/22
06/22

Download Options